MADISON PENDERGRAFT: Open Payments
NPI 1366148306 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,974 in 69 payments from 32 companies in 2025. Trend: 2023 $1,531 · 2024 $1,690 · 2025 $1,974
Food & beverage: $1,775Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $236 |
| Incyte Corporation | 5 | $223 |
| ABBVIE INC. | 2 | $151 |
| E.R. Squibb & Sons, L.L.C. | 8 | $148 |
| Aveo Pharmaceuticals, Inc. | 4 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| Gilead Sciences, Inc. | 2 | $94 |
| BeOne Medicines USA, Inc. | 3 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Merck Sharp & Dohme LLC | 3 | $62 |
Products named: FOTIVDA, RYBREVANT, OPDIVO, CREON, Trodelvy, TEVIMBRA, JAKAFI, KISQALI.
Industry payments across MO — which companies pay providers there.
